Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus

Journal of Clinical Investigation

Volumn 102, Issue 4, 1998, Pages 744-753

  Mevorach, Michèle ^a   Giacca, Adria ^a   Aharon, Yigal ^a   Hawkins, Meredith ^a   Shamoon, Harry ^a   Rossetti, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Endogenous glucose production; Glucokinase; Glucose 6 phosphatase; Hyperglycemia; Type 2 diabetes

Indexed keywords

GLUCAGON; GLUCOKINASE; GLUCOSE 6 PHOSPHATASE; GROWTH HORMONE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; GLYCOLYSIS; GROWTH HORMONE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0032529147     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2720     Document Type: Article

References (59)

1. Kimmerling, G., C. Javorsky, J.M. Olefsky, and G. Reaven. 1976. Demonstration of insulin resistance in untreated adult-onset diabetic subjects with fasting hyperglycemia. Diabetes. 25:673-678.
2. DeFronzo, R.A. 1988. The triumvirate. B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:667-687.
3. Bogardus, C., S. Lillioja, B.V. Howard, G. Reaven, and D. Mott. 1984. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetes mellitus. J. Clin. Invest. 74:1238-1246.
4. Kolterman, O.G., R.S. Gray, J. Griffin, P. Burstein, J. Insel, J.A. Scarlett, and J.M. Olefsky. 1981. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 68: 957-959.
5. Rizza, R.A., L.J. Mandarino, and J.E. Gerich. 1981. Mechanism and significance of insulin resistance in noninsulin-dependent diabetes meltitus. Diabetes. 30:990-995.
6. Thorburn, A.W., B. Gumbiner, F. Bulacan, P. Wallace, and R.R. Henry. 1990. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (Type II) diabetes independent of impaired glucose uptake. J. Clin. Invest. 85:522-529.
7. Young, A.A., C. Bogardus, D. Wolfe-Lopez, and D.M. Mott. 1988. Muscle glycogen synthesis disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage. Diabetes. 37:303-308.
8. 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322:223-228.
9. Wright, K.S., H. Beck-Nielsen, O.G. Kolterman, and L.J. Mandarino. 1988. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM. Diabetes. 37:436-440.
10. Bogardus, C., L. Lillioja, K. Stone, and D. Mott. 1984. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J. Clin. Invest. 73:1186-1190.
11. Lillioja, S., D.M. Mott, J.K. Zawadzki, A.A. Young, W.G. Abbott, and C. Bogardus. 1986. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J. Clin. Endocrinol. Metab. 62:922-927.
12. Soskin, S., and R. Levine. 1946. Carbohydrate Metabolism. University of Chicago Press, Chicago. 247-263.
13. Glinsman, W.H., E.P. Hern, and A. Lynch. 1969. Intrinsic regulation of glucose output by rat liver. Am. J. Physiol. 216:698-703.
14. Sacca, L., R. Hendler, and R.S. Sherwin. 1979. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulalory hormones. J. Clin. Endocrinol. Metab. 47:1160-1163.
15. Shulman, G.I., J.E. Lijenquist, P.E. Williams, W.W. Lacy, and A.D. Cherrington. 1978. Glucose disposal during insulinopenia somatostatin-treated dogs. The roles of glucose and glucagon. J. Clin. Invest. 62:487-491.
16. Shulman, G.I., W.W. Lacy, J.E. Lijenquist, U. Keller, P.E. Williams, and A.D. Cherrington. 1980. Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. J. Clin. Invest. 65:496-505.
17. 14C]-glucose. Diabetes. 35:642-648.
18. Ader, M., G. Pacini, Y.J. Ysug, and R.N. Bergman. 1985. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal model prediction with direct measurements. Diabetes. 34:1092-1103.
19. Ferrannini, E., L. Locatelli, and J.P. Felber. 1989. Differential effects of insulin and hyperglycemia on intracellular glucose dispositions in humans. Metabolism. 38:459-65.
20. Capaldo, B., D. Santoro, G. Riccardi, N. Perrotti, and L. Sacca. 1986. Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type 2 diabetes. J. Clin. Invest. 77:1285-1290.
21. Vaag, A., P. Dambso, O. Hother-Nielsen, and H. Beck-Nielsen. 1992. Hyperglycemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 diabetes mellitus. Diabetologia. 35:80-88.
22. Kelley, D.E., and L.J. Mandarino. 1990. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 86:1999-2007.
23. Del Prato, S., R.C. Bonadonna, E. Bonora, G. Gulli, A. Solini, M. Shank, and R. A. DeFronzo. 1993. Characterization of cellular defects of insulin action in Type 2 (non-insulin-dependent) diabetes mellitus. J. Clin. Invest. 91: 484-494.
24. Welch, S., S.S.P. Gebhart, R.N. Bergman, and L.S. Phillips. 1990. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab. 71:1508-1518.
25. Saad, M.F., R.L. Anderson, A. Laws, R.M. Watanabe, W.W. Kades, Y.-D.I. Chen, R.E. Sands, D. Pei. P.J. Savage, and R.N. Bergman. 1994. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensititvity across the spectrum of glucose tolerance. Diabetes. 43:1114-1121.
26. Basu, A., A. Caumo, F. Bettini, A. Gelisio, A. Alzaid, C. Cobelli, and R.A. Rizza. 1997. Impaired basal glucose effectiveness in NIDDM. Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes. 46:421-432.
27. DeFronzo, R.A., E. Ferrannini, R. Hendler, P. Felig, and J. Wahren. 1983. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 32:35-45.
28. Ludvik, B., J.J. Nolan, A. Roberts, J. Baloga, M. Joyce, J.M. Bell, and J.M. Olefsky. 1995. A noninvasive method to measure splanchic glucose uptake after oral glucose administration. J. Clin. Invest. 95:2232-2238.
29. Efendic, S., S. Karlander, and M. Vranic. 1988. Mild type II diabetes markedly increases glucose cycling in the post-absorptive state and during glucose infusion irrespective of obesity. J. Clin. Invest. 81:1953-1961.
30. Miyoshi, H., G.I. Shulman, E.J. Peters, M.H. Wolfe, D. Elahi, and R.R. Wolfe. 1988. Hormonal control of substrate cycling in humans. J. Clin. Invest. 81:1545-1555.
31. Shamoon, H., S. Friedman, C. Canton, L. Zacharowicz, M. Hu, and L. Rossetti. 1994. Increased epinephrine and skeletal muscle responses to hypoglycemia in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 93:2562-2571.
32. Finegood, D.T., R.N. Bergman, and M. Vranic. 1987. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamp: comparison of unlabeled and labeled glucose infusates. Diabetes. 36: 914-924.
33. 14C) labels. Am. J. Physiol. 230:1159-1162.
34. Sotsky, M.J., S. Shilo, and H. Shamoon. 1989. Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia. J. Clin. Endocrinol. Metab. 68:9-17.
35. Gawehn, K. 1986. D-Lactate. In Methods of Enzymatic Analysis. H. Bergmeyer and M. Gassl. editors. Academic Press, Inc., New York. 6:583-592.
36. Hawk, P. 1947. The Kjeldahl method. In Practical Physiological Chemistry. 12th ed. Toronto, Blakiston. 814-822.
37. Steele, R. 1959. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. NY Acad. Sci. 82:420-430.
38. Rossetti, L., and A. Giaccari. 1990. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J. Clin. Invest. 85:1785-1792.
39. Rossetti, L., Y.-T. Lee, J. Ruiz, S. Aldridge, H. Shamoon, and G. Boden. 1993. Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am. J. Physiol. 265:E761-E769.
40. Lusk, G. 1924. Animal calorimetry: analysis of the oxidation of mixtures of carbohydrate and fat. J. Biol. Chem. 59:41-42.
41. Ader, M., T.-C. Ni, and R.N. Bergman. 1997. Glucose effectiveness assessed under dynamic and steady-state conditions. Comparability of uptake versus production components. J. Clin. Invest. 99:1187-1199.
42. Cohen, N., M. Halberstam, P. Shlimovich, C.J. Chang, H. Shamoon, and L. Rossetti. 1995. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin dependent diabetes mellitus. J. Clin. Invest. 95:2501-2509.
43. Halberstam, M., N. Cohen, L. Rossetti, and H. Shamoon. 1996. Oral vanadyl sulfate enhances hepatic and peripheral insulin sensitivity in obese patients with NIDDM, but not in non diabetic obese subjects. Diabetes. 45:659-666.
44. Farrace, S., and L. Rossetti. 1992. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats. Diabetes. 41:1453-1463.
45. Baron, A.D., G. Brechtel, P. Wallace, and S.V. Edelman. 1988. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255:E769-E774.
46. Rossetti, L., A. Giaccari, N. Barzilai, K. Howard, G. Sebel, and M. Hu. 1993. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia. J. Clin. Invest. 92:1126-1134.
47. Barzilai, N., M. Hawkins, I. Angelov, M. Hu, and L. Rossetti. 1996. Glucosamine-induced inhibition of liver glucokinasc impairs the ability of hyperglycemia to suppress endogeneous glucose production. Diabetes. 45:1329-1335.
48. Rossetti, L., W. Chen, M. Hu, M. Hawkins, N. Barzilai, and S. Efrat. 1997. Abnormal regulation of hepatic glucose production by hyperglycemia in mice with a disrupted glucokinase allele. Am. J. Physiol. 273:E743-E750.
49. Shi, Z.Q., A. Giacca, S. Fisher, H. Vidal, G. van de Werve, and M. Vranic. 1994. Importance of substrate changes in the decrease of hepatic glucose cycling during insulin infusion and declining glycemia in the depancreatectomized dog. Diabetes. 43:1284-1290.
50. Felig, P., J. Wahren, and R. Hendler. 1978. Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes. 27:121-126.
51. Firth, R., P. Marsh, I. Hansen, and R. Rizza. 1986. Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus: role of hepatic and extrahepatic tissues. J. Clin. Invest. 77:1525-1532.
52. Ludvik, B., J.J. Nolan, A. Roberts, J. Baloga, M. Joyce, J.M. Bell, and J.M. Olefsky. 1997. Evidence for decreased splanchic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 100:2354-2361.
53. Alzaid, A.A., S.F. Dinneen, D.J. Turk, A. Caumo, C. Cobelli, and R.A. Rizza. 1994. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J. Clin. Invest. 94:2341-2348.
54. Rebrin, K., G.M. Steil, L. Getty, and R.N. Bergman. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
55. Rebrin, K., G.M. Steil, S.D. Mittelman, and R.N. Bergman. 1996. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98:741-749.
56. Sindelar, D.K., C.A. Chu, M. Rohlie, D.W. Neal, L.L. Swift, and A.D. Cherrington. 1997. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes. 46:187-196.
57. Lewis, G.F., M. Vranic, P. Harley, and A. Giacca. 1997. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes. 46:1111-1119.
58. Boden, G., X. Chen, J. Ruiz, J.V. White, and L. Rossetti. 1994. Mechanisms of fatty acids induced inhibition of glucose uptake. J. Clin. Invest. 93: 2438-2446.
59. Puhakainen, I., and H. Yki-Jarvinen. 1993. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes. 42:1694-1699.